The science
This mask's barrier claim rests on two ingredients with real evidence, one with promising evidence, and one printed on the front that has none at the declared dose. Panthenol is the first. Topical dexpanthenol has decades of clinical use in wound care and barrier support, and a 2002 review in the American Journal of Clinical Dermatology by Ebner and colleagues summarised trials showing that 5% dexpanthenol accelerated barrier recovery after sodium lauryl sulfate irritation, improved stratum corneum hydration and reduced transepidermal water loss. The mask's declared 1% is a fifth of that, but the panthenol is delivered daily under a wet occlusive sheet, a format that increases penetration of water-soluble humectants, and even lower concentrations have shown hydration effects in cosmetic testing. Niacinamide is the second. Tanno and colleagues showed in a 2000 British Journal of Dermatology paper that niacinamide upregulates ceramide and free fatty acid synthesis in cultured keratinocytes and, in a clinical arm, improved barrier function and reduced transepidermal water loss in dry-skin subjects over four to eight weeks. Third position in a water-based essence implies a low-single-digit concentration, in the range those studies used.
Ectoin is the promising one. A 2022 systematic review in Dermatology and Therapy pooled six clinical studies and found that 5.5 to 7% ectoin formulations improved dryness and dermatitis scores in mild-to-moderate atopic dermatitis — in one randomised, double-blind trial performing on a par with a non-steroidal anti-inflammatory comparator cream — and were well tolerated in infants and children, an effect attributed to the hydration shell ectoin forms around cell membranes; the concentration here is undisclosed and certainly lower, but it is the right molecule for the brief. Beta-sitosterol is the fourth. Phytosterols do have documented anti-inflammatory and barrier-lipid roles, but the studies involve percent-level concentrations in emollients; 750 parts per billion is orders of magnitude below any tested dose, and Some By Mi's own declaration is the clearest evidence that it is not doing pharmacological work.
The hyaluronate complex, allantoin and licorice-derived glycyrrhizate are established humectant and soothing agents whose contribution to a ten-minute mask is transient surface hydration and mild redness reduction. As with every product in the range, no trial of this specific mask exists, so the assessment is a synthesis of ingredient-level evidence and formulation position, not a test of the finished product.
References 3 ShowHide
- Topical use of dexpanthenol in skin disorders — American Journal of Clinical Dermatology (2002)
- Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier — British Journal of Dermatology (2000)
- Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review — Dermatology and Therapy (2022)